Link to Full Article Cambridge, United Kingdom and Singapore – 13 April 2021– Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a strategic partnership with Camtech Diagnostics (“Camtech”), a technology company providing total solutions to the biodefence, food and clinical diagnostics sectors. The partnership […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-04-13 04:21:432021-04-20 04:23:09Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Link to Full Article Cambridge, United Kingdom – 6 April 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Jayesh Pankhania as Chief Financial Officer (CFO), effective immediately. Jayesh is a finance professional with nearly 30 years of global […]
Link to Full Article Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new contract with the Institute of Immunology and Genetics (‘IIG’ or the ‘Institute’) a leading molecular genetic laboratory in Kaiserslautern, Germany, equipped with state-of-the-art equipment and comprehensive human genetic and bioinformatic expertise. From analysis of established gene variants, […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-31 04:17:352021-04-20 04:19:34Comgenica selected by Institute of Immunology and Genetics in Kaiserslautern to accelerate its whole exome sequencing
Link to Full Article Coveted award for Phase II clinical development of lead product, AT247, its next generation ultra-rapid acting Insulin Cambridge, UK., 31 st Mar 2021: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has been awarded a £2.8 million grant from […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-31 04:05:102021-04-20 04:11:47ARECOR RECEIVES £2.8 MILLION GRANT AWARD FROM INNOVATE UK
Link to Full Article Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel Primary endpoint achieved with >99% nasal bacterial load reduction (p<0.0001) Excellent safety profile. No treatment related adverse events Brighton, United Kingdom – 29th March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development of novel […]
Link to Full Article Sioux Falls, South Dakota, United States and Cambridge, UK – 25 March 2021 Sanford Health (‘Sanford’), a leading US-based healthcare delivery system provider and Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peoples’ lives, today announce a genomics partnership focused on providing answers for patients […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-25 04:15:012021-04-20 04:17:00Multi-year study will use Congenica’s platform for rapid and accurate genomic analysis
Link to Full Article MARINA DEL REY, Calif., March 18, 2021 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced results for the fourth quarter and full year 2020 and provided a corporate and clinical update. Fourth Quarter […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-18 03:23:432021-03-19 03:24:58Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
Link to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Notice of Full Year Results and Clinical Trial Update Brighton, United Kingdom – 16th March 2021 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, will announce its financial results for […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-15 03:33:072021-03-19 03:33:54Notice of Full Year Results and Clinical Trial Update
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Agreement with NIAID to Evaluate a Novel XF-73 Formulation in Skin Wound Infection Brighton, United Kingdom, 15 March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, announces […]
Link to Full Article AmpliTech to distribute Congenica’s world-leading NGS data analysis and clinical decision support software in France Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new distribution agreement with AmpliTech, a leading French distribution company dedicated to the commercialisation of innovative products, software, and instruments for in […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-15 03:26:482021-03-19 03:29:11Congenica signs distribution agreement with AmpliTech in France
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
/in CongenicaLink to Full Article Cambridge, United Kingdom and Singapore – 13 April 2021– Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a strategic partnership with Camtech Diagnostics (“Camtech”), a technology company providing total solutions to the biodefence, food and clinical diagnostics sectors. The partnership […]
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
/in CongenicaLink to Full Article Cambridge, United Kingdom – 6 April 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Jayesh Pankhania as Chief Financial Officer (CFO), effective immediately. Jayesh is a finance professional with nearly 30 years of global […]
Comgenica selected by Institute of Immunology and Genetics in Kaiserslautern to accelerate its whole exome sequencing
/in CongenicaLink to Full Article Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new contract with the Institute of Immunology and Genetics (‘IIG’ or the ‘Institute’) a leading molecular genetic laboratory in Kaiserslautern, Germany, equipped with state-of-the-art equipment and comprehensive human genetic and bioinformatic expertise. From analysis of established gene variants, […]
ARECOR RECEIVES £2.8 MILLION GRANT AWARD FROM INNOVATE UK
/in ArecorLink to Full Article Coveted award for Phase II clinical development of lead product, AT247, its next generation ultra-rapid acting Insulin Cambridge, UK., 31 st Mar 2021: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has been awarded a £2.8 million grant from […]
Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel
/in Destiny PharmaLink to Full Article Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel Primary endpoint achieved with >99% nasal bacterial load reduction (p<0.0001) Excellent safety profile. No treatment related adverse events Brighton, United Kingdom – 29th March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development of novel […]
Multi-year study will use Congenica’s platform for rapid and accurate genomic analysis
/in CongenicaLink to Full Article Sioux Falls, South Dakota, United States and Cambridge, UK – 25 March 2021 Sanford Health (‘Sanford’), a leading US-based healthcare delivery system provider and Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peoples’ lives, today announce a genomics partnership focused on providing answers for patients […]
Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Results and Provides General Corporate Update
/in Armata PharmaceuticalsLink to Full Article MARINA DEL REY, Calif., March 18, 2021 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced results for the fourth quarter and full year 2020 and provided a corporate and clinical update. Fourth Quarter […]
Notice of Full Year Results and Clinical Trial Update
/in Destiny PharmaLink to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Notice of Full Year Results and Clinical Trial Update Brighton, United Kingdom – 16th March 2021 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, will announce its financial results for […]
Destiny Pharma Announces Agreement with NIAID
/in Destiny PharmaDestiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Agreement with NIAID to Evaluate a Novel XF-73 Formulation in Skin Wound Infection Brighton, United Kingdom, 15 March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, announces […]
Congenica signs distribution agreement with AmpliTech in France
/in CongenicaLink to Full Article AmpliTech to distribute Congenica’s world-leading NGS data analysis and clinical decision support software in France Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new distribution agreement with AmpliTech, a leading French distribution company dedicated to the commercialisation of innovative products, software, and instruments for in […]